ATI Advisory

If you'll be at our PALTC24 Annual Conference in San Antonio, thank you. We can't wait to see you there. Please tag any posts with #PALTC24.

Big things are coming for SNP Alliance... You may have already noticed our new logo here on X, and we also have a brand new office! Keep your eyes on our website as well, as some fresh updates will be happening there soon. 👀 #Healthcare #SpecialNeedsPlans

In their new Forefront article, @BenzingLaura Allison Rizer + @annetumlinson of @ATIAdvisory argue that state policy makers can improve person-centered care for dual-eligible people with limited English proficiency and their caregivers with certain tools. bit.ly/42eqGlf

Obit of Dick Schlosberg, who was a great @KFF trustee as well as @latimes publisher latimes.com/california/sto…

@ATIAdvisory: Post-acute providers should revisit strategies to keep up with evolving payment landscape #homecare #homehealth #medicare brnw.ch/21wFZBL

It was great to join @AnneTumlinson and host Rosanne Corcoran on daughterhood the podcast to discuss #aging policy issues. You can listen here: daughterhoodthepodcast.com/podcast/episod… @RosannePodcast

Does every nursing home need a value-based care strategy today? Brian Fuller, ATI ’s managing director of value-based care design and delivery, says: unequivocally yes. Nursing homes not planning for value-based care are falling behind mcknights.com/resources/news… via @KimMarselas

.@a_kaltenboeck: “They're going to eventually make decisions re: #IRA... What's important to remember is that the sort of assertions they make for a policy signaling and a lobbying perspective...doesn't always reflect what the true business decision actually is."

Major Changes In Drug R&D Trends Unlikely To Be Tied To Negotiation, Analysis Finds via @greatgabhoudini insidehealthpolicy.com/daily-news/maj…

.@a_kaltenboeck: “[NCP] suggests ICER’s net price data might be inaccurate, but don’t mention ICER created a process for companies to submit corrections. (T)hey state the data are old, but the (evaluation) timeframe ensures the data on net prices & new evidence is more complete.”

ICER: Price Hikes Of 8 Drugs Without Clinical Evidence Adds $1.3B To Health Care Spending via @MaaishaO insidehealthpolicy.com/daily-news/ice…

How planning for long-term care is burdening middle-class Americans -- my interview on @NewsHour pbs.org/newshour/show/…

So awesome — for everyone — that you are a part of this!

What to know about #HomeHealthcare and #HomeCare Excellent explainer article from @EastabrookDiane and @modrnhealthcr (And yes we get asked the difference a lot!) modernhealthcare.com/providers/home…

Insights on Exposing, Resolving Chronic Underfunding of Nursing Homes: skillednursingnews.com/2023/12/insigh… from @skilled_nursing

Seniors Aren’t Getting Enough Financial Support To Afford Home-Based Care: homehealthcarenews.com/2023/12/senior… from @HHCareNews

Long-term care challenges require federal attention: panel mcknightsseniorliving.com/home/news/long… from @KimBonvissuto and @_McKnightsSL

This is @ReedAbelson and my @AHCJ discussion of our reporting on long-term care for our #DyingBroke series in the @nytimes & @KFFHealthNews healthjournalism.org/blog/2023/12/h…

The toll of providing and paying for #LongTermCare is a growing financial and emotional crisis for Americans. Join @KFFHealthNews @jordanrau, @ATIAdvisory @annetumlinson, @nytimes @ReedAbelson & caregivers Robert Ingenito & Angela Jemmott to learn more: bit.ly/47I116b

In their new Forefront article, @a_kaltenboeck, Jennifer Chen + @nancyyu0808 of @ATIAdvisory argue that the recent Forefront article on the Medicare price negotiation program on market entry of new drugs has a narrow view of incentives of clinical studies. bit.ly/47VUWTB